President Biden, citing the need for maximum flexibility in the nation’s vaccination program, today announced a deal for the U.S. government to purchase an additional 100 million doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

Johnson & Johnson is working with Merck to increase supply, making such a deal possible.

The purchase doubles the nation’s projected supply of Johnson & Johnson doses, to 200 million. The intent of the purchase is to prepare for long-term supply needs, including the eventual vaccination of children and the possible need for booster shots to protect against COVID-19 variants.

Related News Articles

Headline
In a study of 151 tax-exempt hospitals reported yesterday in JAMA Network Open, 84% updated their charity care policies between 2019 and 2021. Among the…
Headline
Pfizer has submitted a request for the Food and Drug Administration to authorize a 10-microgram booster dose of its bivalent COVID-19 vaccine booster for…
Headline
Health care providers who treat uninsured or underinsured patients with commercially procured bebtelovimab, a COVID-19 monoclonal antibody therapy for…
Headline
The Centers for Medicare & Medicaid Services Friday reopened the comment period for a 2020 interim final rule that set forth certain requirements for…
Headline
Moderna Friday submitted its request that the Food and Drug Administration authorize for emergency use its bivalent COVID-19 vaccine for children and…
Headline
The Centers for Disease Control and Prevention Friday updated its COVID-19 infection control guidance for U.S. health care settings based on current…